Delivery Order SPE2DB20D1110-SPE2DB24FK33M

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, worth $7,798.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,153,745 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract, with a completion date of February 5, 2025. The contract is not designated as a set-aside award. In addition to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,213.90 firm fixed price delivery order is for 4,562,939,579 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,554.95 Firm Fixed Price delivery order is for the supply of 4,566,760,843 units of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,481.13 contract is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of May 28, 2024 and was awarded on May 24, 2024. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.08 delivery order contract is for the provision of 4566688936 - Ondansetron ODT 4 MG Tablet 30S, a medication used to prevent nausea and vomiting. The contract has a firm fixed price pricing type and a completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,069.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,083 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set-aside and is open to competition....
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,041.90 firm fixed-price delivery order is for the supply of 4560995849 - Ondansetron ODT 4 MG Tablet 30S, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which provides a comprehensive...
This federal contract award was made by the Medical Supply Chain component of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,163.32 firm fixed-price delivery order is for Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of October 31, 2023 and was awarded on October 30, 2023. This order is part of a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.49 firm fixed-price delivery order is for 4,566,718,202 units of the medication Ondansetron ODT 4 mg tablets, a common anti-nausea drug. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. It is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,952.03 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK33M
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,703.06 firm fixed-price delivery order is for the supply of 4,564,997,915 units of the medication Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has a completion date of June 26, 2024 and was awarded on June 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:03 AM